| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.014 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |